Aurobindo Pharma Ltd — Ramipril Exporter Profile
Indian Pharmaceutical Exporter · #3 for Ramipril · $13.3M export value · DGFT Verified
Aurobindo Pharma Ltd is the #3 Indian exporter of Ramipril with $13.3M in export value and 811 verified shipments. Aurobindo Pharma Ltd holds a 14.8% market share in Ramipril exports across 8 countries.
Aurobindo Pharma Ltd — Ramipril Export Profile: Buyers & Destinations
Where Does Aurobindo Pharma Ltd Export Ramipril?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $7.2M | 387 | 56.8% |
| UNITED KINGDOM | $1.7M | 127 | 13.7% |
| MALTA | $1.7M | 366 | 13.2% |
| SPAIN | $831.6K | 26 | 6.6% |
| FRANCE | $412.1K | 47 | 3.2% |
| CANADA | $392.0K | 115 | 3.1% |
| ISRAEL | $305.7K | 12 | 2.4% |
| UNITED STATES OF AMERICA | $114.7K | 5 | 0.9% |
| NETHERLANDS | $11.2K | 2 | 0.1% |
Aurobindo Pharma Ltd exports Ramipril to 9 countries. The largest destination is UNITED STATES accounting for 56.8% of Aurobindo Pharma Ltd's Ramipril shipments, followed by UNITED KINGDOM (13.7%) and MALTA (13.2%). These destinations reflect Aurobindo Pharma Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ramipril from Aurobindo Pharma Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $1.2M | 46 |
| APL SWIFT SERVICES (MALTA) LTD., | MALTA | $1.2M | 257 |
| RISING PHARMA HOLDINGS, INC. | UNITED STATES | $893.6K | 63 |
| RISING PHARMA HOLDINGS INC | UNITED STATES | $861.6K | 30 |
| MILPHARM LIMITED, | UNITED KINGDOM | $802.4K | 52 |
| AUROLOGISTICS LLC (AUROBINDO PHARMA | UNITED STATES | $712.2K | 41 |
| AUROLOGISTICS LLC | UNITED STATES | $666.5K | 32 |
| RISING PHARMA HOLDINGS, INC. ,. | UNITED STATES | $580.9K | 28 |
| AUROLOGISTICS LLC AUROBINDO PHARM | UNITED STATES | $563.9K | 23 |
| RISING PHARMA HOLDINGS, INC. , | UNITED STATES | $487.9K | 34 |
Aurobindo Pharma Ltd supplies Ramipril to 54 buyers globally. The largest buyer is AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES), followed by APL SWIFT SERVICES (MALTA) LTD., (MALTA) and RISING PHARMA HOLDINGS, INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ramipril Export Value and How Much Does Aurobindo Pharma Ltd Contribute?
India exported $82.5M worth of Ramipril through 4,977 shipments from 177 suppliers to 93 countries, serving 389 buyers globally. Aurobindo Pharma Ltd contributes $13.3M to this total, accounting for 14.8% of India's Ramipril exports. Aurobindo Pharma Ltd ships Ramipril to 9 countries through 54 buyers.
What Is the Average Shipment Value for Aurobindo Pharma Ltd's Ramipril Exports?
Aurobindo Pharma Ltd's average Ramipril shipment value is $16.4K per consignment, based on 811 shipments totaling $13.3M. The largest destination is UNITED STATES (56.8% of Aurobindo Pharma Ltd's Ramipril exports).
How Does Aurobindo Pharma Ltd Compare to Other Indian Ramipril Exporters?
Aurobindo Pharma Ltd ranks #3 among 177 Indian Ramipril exporters with a 14.8% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($16.0M), GENO PHARMACEUTICALS PRIVATE LIMITED ($14.0M), AUROBINDO PHARMA LTD ($13.3M). Aurobindo Pharma Ltd processed 811 shipments to 8 destination countries.
What Ramipril Formulations Does Aurobindo Pharma Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RAMIPRIL CAPSULES 10 MG (5760X500'S) | $200.0K | 4 |
| RAMIPRIL 5 MG TABLETS (RAMIPRIL CINFA 5MG COMPRIMIDOS EFG) 28'S | $179.1K | 6 |
| RAMIPRIL CAPSULES 5.0 MG (RAMIPRIL CAPSU | $165.6K | 8 |
| RAMIPRIL CAPSULES 2.5 MG(RAMIPRIL 2.5MG | $157.1K | 4 |
| RAMIPRIL CAPSULES 10 MG (RAMIPRIL CAPSULES USP 10 MG) 500"S (19121 X 500'S PACK= 9560500 NO'S)NOS | $150.0K | 3 |
| RAMIPRIL CAPSULES 10 MG (RAMIPRIL CAPSUL | $149.9K | 3 |
| RAMIPRIL CAPSULES 10 MG(17328X500'S)NOS | $148.1K | 3 |
| RAMIPRIL CAPSULES 10 MG (RAMIPRIL CAPSULES USP 10 MG) 500'S | $142.0K | 3 |
| RAMIPRIL CAPSULES 1.25 MG(RAMIPRIL 1.25M | $126.9K | 7 |
| RAMIPRIL CAPSULES 10 MG(RAMIPRIL 10MG CA | $126.0K | 5 |
Aurobindo Pharma Ltd exports 603 distinct Ramipril formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RAMIPRIL CAPSULES 10 MG (5760X500'S) with 4 shipments worth $200.0K.
Regulatory Requirements: Exporting Ramipril to Key Markets
What Aurobindo Pharma Ltd must comply with to export Ramipril to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Aurobindo Pharma Ltd Compare to Nearest Ramipril Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LIMITED | $16.0M | 320 | 5 | $50.0K |
| 2 | GENO PHARMACEUTICALS PRIVATE LIMITED | $14.0M | 686 | 1 | $20.5K |
| 3 | AUROBINDO PHARMA LTD ★ | $13.3M | 811 | 8 | $16.4K |
| 5 | IND SWIFT LIMITED | $6.4M | 307 | 3 | $20.8K |
| 6 | ZENTIVA PRIVATE LIMITED | $4.9M | 233 | 5 | $21.0K |
Aurobindo Pharma Ltd ranks #3 among 177 Indian Ramipril exporters. Average shipment value of $16.4K compared to the market average of $466.2K. The closest competitors by value are MYLAN LABORATORIES LIMITED and GENO PHARMACEUTICALS PRIVATE LIMITED.
Which Indian Ports Ship Ramipril Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 658 | 13.2% |
| JNPT/ NHAVA SHEVA SEA | 553 | 11.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 305 | 6.1% |
| SAHAR AIR | 291 | 5.8% |
| JNPT | 271 | 5.4% |
| DELHI AIR CARGO ACC (INDEL4) | 214 | 4.3% |
| DELHI AIR | 201 | 4.0% |
| VIZAG SEA | 194 | 3.9% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ramipril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ramipril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 1,087 individual customs records matching Aurobindo Pharma Ltd exporting Ramipril, covering 603 formulations to 9 countries via 54 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 93+ countries, 389+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ramipril Export Data from Aurobindo Pharma Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aurobindo Pharma Ltd's Ramipril exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aurobindo Pharma Ltd
Company Profile
0 products · $0 total trade · 0 categories
Ramipril Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aurobindo Pharma Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ramipril. For current shipment-level data, contact TransData Nexus.